|
1
|
Yamashita T and Kaneko S: Liver cancer.
Rinsho Byori. 64:787–796. 2016.(In Japanese). PubMed/NCBI
|
|
2
|
Li L and Wang H: Heterogeneity of liver
cancer and personalized therapy. Cancer Lett. 379:191–197. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Anwanwan D, Singh SK, Singh S, Saikam V
and Singh R: Challenges in liver cancer and possible treatment
approaches. Biochim Biophys Acta Rev Cancer. 1873:1883142020.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zheng R, Qu C, Zhang S, Zeng H, Sun K, Gu
X, Xia C, Yang Z, Li H, Wei W, et al: Liver cancer incidence and
mortality in China: Temporal trends and projections to 2030. Chin J
Cancer Res. 30:571–579. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shiraha H, Iwamuro M and Okada H: Hepatic
stellate cells in liver tumor. Adv Exp Med Biol. 1234:43–56. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Losic B, Craig AJ, Villacorta-Martin C,
Martins-Filho SN, Akers N, Chen X, Ahsen ME, von Felden J, Labgaa
I, D'Avola D, et al: Intratumoral heterogeneity and clonal
evolution in liver cancer. Nat Commun. 11:2912020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo Z, Chen W, Dai G and Huang Y:
Cordycepin suppresses the migration and invasion of human liver
cancer cells by downregulating the expression of CXCR4. Int J Mol
Med. 45:141–150. 2020.PubMed/NCBI
|
|
8
|
Liu CY, Chen KF and Chen PJ: Treatment of
Liver Cancer. Cold Spring Harb Perspect Med. 5:a0215352015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chan LK and Ng IO: Joining the dots for
better liver cancer treatment. Nat Rev Gastroenterol Hepatol.
17:74–75. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Phillips WT, Bao A, Brenner AJ and Goins
BA: Image-guided interventional therapy for cancer with
radiotherapeutic nanoparticles. Adv Drug Deliv Rev. 76:39–59. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
French JT, Goins B, Saenz M, Li S,
Garcia-Rojas X, Phillips WT, Otto RA and Bao A: Interventional
therapy of head and neck cancer with lipid nanoparticle-carried
rhenium 186 radionuclide. J Vasc Interv Radiol. 21:1271–1279. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Weyerhäuser P, Kantelhardt SR and Kim EL:
Re-purposing chloroquine for glioblastoma: Potential merits and
confounding variables. Front Oncol. 8:3352018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Borba MGS, Val FFA, Sampaio VS, Alexandre
MAA, Melo GC, Brito M, Mourao MPG, Brito-Sousa JD, Baia-da-Silva D,
Guerra MVF, et al: Effect of high vs low doses of chloroquine
diphosphate as adjunctive therapy for patients hospitalized with
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection: A randomized clinical trial. JAMA Netw Open.
3:e2088572020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kashyap A, Kaur R, Baldi A, Jain UK,
Chandra R and Madan J: Chloroquine diphosphate bearing dextran
nanoparticles augmented drug delivery and overwhelmed drug
resistance in Plasmodium falciparum parasites. Int J Biol
Macromol. 114:161–168. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei DM, Jiang MT, Lin P, Yang H, Dang YW,
Yu Q, Liao DY, Luo DZ and Chen G: Potential ceRNA networks involved
in autophagy suppression of pancreatic cancer caused by chloroquine
diphosphate: A study based on differentially-expressed circRNAs,
lncRNAs, miRNAs and mRNAs. Int J Oncol. 54:600–626. 2019.PubMed/NCBI
|
|
16
|
Jiang PD, Zhao YL, Deng XQ, Mao YQ, Shi W,
Tang QQ, Li ZG, Zheng YZ, Yang SY and Wei YQ: Antitumor and
antimetastatic activities of chloroquine diphosphate in a murine
model of breast cancer. Biomed Pharmacother. 64:609–614. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sasaki K, Tsuno NH, Sunami E, Kawai K,
Hongo K, Hiyoshi M, Kaneko M, Murono K, Tada N, Nirei T, et al:
Resistance of colon cancer to 5-fluorouracil may be overcome by
combination with chloroquine, an in vivo study. Anticancer Drugs.
23:675–682. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Godoy P, Hewitt NJ, Albrecht U, Andersen
ME, Ansari N, Bhattacharya S, Bode JG, Bolleyn J, Borner C, Bottger
J, et al: Recent advances in 2D and 3D in vitro systems using
primary hepatocytes, alternative hepatocyte sources and
non-parenchymal liver cells and their use in investigating
mechanisms of hepatotoxicity, cell signaling and ADME. Arch
Toxicol. 87:1315–1530. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miyamoto Y, Ikeuchi M, Noguchi H, Yagi T
and Hayashi S: Spheroid formation and evaluation of hepatic cells
in a three-dimensional culture device. Cell Med. 8:47–56. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mazzei M, Vascellari M, Zanardello C,
Melchiotti E, Vannini S, Forzan M, Marchetti V, Albanese F and
Abramo F: Quantitative real time polymerase chain reaction
(qRT-PCR) and RNAscope in situ hybridization (RNA-ISH) as effective
tools to diagnose feline herpesvirus-1-associated dermatitis. Vet
Dermatol. 30:491–e147. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Browning DJ: Pharmacology of chloroquine
and hydroxychloroquine. Hydroxychloroquine and Chloroquine
Retinopathy. Browning DJ: Springer; New York, NY: pp. 35–63. 2014,
View Article : Google Scholar
|
|
22
|
Faustino-Rocha A, Oliveira PA,
Pinho-Oliveira J, Teixeira-Guedes C, Soares-Maia R, da Costa RG,
Colaco B, Pires MJ, Colaco J, Ferreira R and Ginja M: Estimation of
rat mammary tumor volume using caliper and ultrasonography
measurements. Lab Anim (NY). 42:217–224. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yin YB, de Jonge HR, Wu X and Yin YL:
Mini-gut: A promising model for drug development. Drug Discov
Today. 24:1784–1794. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kawai T, Yasuchika K, Ishii T, Miyauchi Y,
Kojima H, Yamaoka R, Katayama H, Yoshitoshi EY, Ogiso S, Kita S, et
al: SOX9 is a novel cancer stem cell marker surrogated by
osteopontin in human hepatocellular carcinoma. Sci Rep.
6:304892016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ferner RE and Aronson JK: Chloroquine and
hydroxychloroquine in covid-19. BMJ. 369:m14322020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Multicenter collaboration group of
Department of Science and Technology of Guangdong Province and
Health Commission of Guangdong Province for chloroquine in the
treatment of novel coronavirus pneumonia, . Expert consensus on
chloroquine phosphate for the treatment of novel coronavirus
pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 43:185–188. 2020.(In
Chinese). PubMed/NCBI
|
|
27
|
Aye T and Arndt PA: Utility of chloroquine
diphosphate in the blood bank laboratory. Immunohematology.
34:98–102. 2018.PubMed/NCBI
|
|
28
|
Meinao IM, Sato EI, Andrade LE, Ferraz MB
and Atra E: Controlled trial with chloroquine diphosphate in
systemic lupus erythematosus. Lupus. 5:237–241. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang J, Wang C, Hu X, Yu C, Zhou L, Ding Z
and Zhou M: Gefitinib-mediated apoptosis is enhanced via inhibition
of autophagy by chloroquine diphosphate in cutaneous squamous cell
carcinoma cells. Oncol Lett. 18:368–374. 2019.PubMed/NCBI
|
|
30
|
Hu T, Li P, Luo Z, Chen X, Zhang J, Wang
C, Chen P and Dong Z: Chloroquine inhibits hepatocellular carcinoma
cell growth in vitro and in vivo. Oncol Rep.
35:43–49. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fan C, Wang W, Zhao B, Zhang S and Miao J:
Chloroquine inhibits cell growth and induces cell death in A549
lung cancer cells. Bioorg Med Chem. 14:3218–3222. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Brooks R and Bannigan K: Occupational
therapy interventions in child and adolescent mental health: A
mixed methods systematic review protocol. JBI Database System Rev
Implement Rep. 16:1764–1771. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guan YS and Liu Y: Interventional
treatments for hepatocellular carcinoma. Hepatobiliary Pancreat Dis
Int. 5:495–500. 2006.PubMed/NCBI
|
|
34
|
Perez-Garijo A, Fuchs Y and Steller H:
Apoptotic cells can induce non-autonomous apoptosis through the TNF
pathway. Elife. 2:e010042013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wong RS: Apoptosis in cancer: From
pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pistritto G, Trisciuoglio D, Ceci C,
Garufi A and D'Orazi G: Apoptosis as anticancer mechanism: Function
and dysfunction of its modulators and targeted therapeutic
strategies. Aging (Albany NY). 8:603–619. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liang Q, Xiao Y, Liu K, Zhong C, Zeng M
and Xiao F: Cr(VI)-induced autophagy protects L-02 hepatocytes from
apoptosis through the ROS-AKT-mTOR pathway. Cell Physiol Biochem.
51:1863–1878. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yan L, Guo N, Cao Y, Zeng S, Wang J, Lv F,
Wang Y and Cao X: miRNA-145 inhibits myocardial infarction-induced
apoptosis through autophagy via Akt3/mTOR signaling pathway in
vitro and in vivo. Int J Mol Med. 42:1537–1547.
2018.PubMed/NCBI
|
|
39
|
Tong Y, Zhang G, Li Y, Xu J, Yuan J, Zhang
B, Hu T and Song G: Corilagin inhibits breast cancer growth via
reactive oxygen species-dependent apoptosis and autophagy. J Cell
Mol Med. 22:3795–3807. 2018.(Epub ahead of print). View Article : Google Scholar
|
|
40
|
Zeng Y, Li S, Wu J, Chen W, Sun H, Peng W,
Yu X and Yang X: Autophagy inhibitors promoted aristolochic acid I
induced renal tubular epithelial cell apoptosis via mitochondrial
pathway but alleviated nonapoptotic cell death in mouse acute
aritolochic acid nephropathy model. Apoptosis. 19:1215–1224. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hu H, Gehart H, Artegiani B,
LÖpez-Iglesias C, Dekkers F, Basak O, van Es J, Chuva de Sousa
Lopes SM, Begthel H, Korving J, et al: Long-term expansion of
functional mouse and human hepatocytes as 3D organoids. Cell.
175:1591–1606 e19. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dutta D and Clevers H: Organoid culture
systems to study host-pathogen interactions. Curr Opin Immunol.
48:15–22. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yin Y, Chen S, Hakim MS, Wang W, Xu L,
Dang W, Qu C, Verhaar AP, Su J, Fuhler GM, et al: 6-Thioguanine
inhibits rotavirus replication through suppression of Rac1 GDP/GTP
cycling. Antiviral Res. 156:92–101. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Angelini F, Corbetti F, Nassuato G,
Okolicsanyi L and Zacchi C: Echography with portable equipment. Its
possibilities and limits in the hepatobiliary area. Radiol Med.
76:337–339. 1988.(In Italian). PubMed/NCBI
|
|
45
|
Yin YB, de Jonge HR, Wu X and Yin YL:
Enteroids for nutritional studies. Mol Nutr Food Res.
63:e18011432019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Nuciforo S, Fofana I, Matter MS, Blumer T,
Calabrese D, Boldanova T, Piscuoglio S, Wieland S, Ringnalda F,
Schwank G, et al: Organoid models of human liver cancers derived
from tumor needle biopsies. Cell Rep. 24:1363–1376. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sun L, Wang Y, Cen J, Ma X, Cui L, Qiu Z,
Zhang Z, Li H, Yang RZ, Wang C, et al: Modelling liver cancer
initiation with organoids derived from directly reprogrammed human
hepatocytes. Nat Cell Biol. 21:1015–1026. 2019. View Article : Google Scholar : PubMed/NCBI
|
